In the US medical devices industry, there were 74 M&A deals announced in Q3 2024, worth a total value of $11.5bn, according to GlobalData’s Deals Database. The $3.8bn acquisition of Baxter International by Carlyle Group was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, M&A activity in the US decreased by 42% in Q3 2024 compared with the previous quarter’s total of $19.9bn and rose by 644% as compared to Q3 2023. Related deal volume increased by 28% in Q3 2024 versus the previous quarter and was 37% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in the US in 9M 2024 were Jefferies Financial Group; Citigroup; Perella Weinberg Partners with 5, 3, 3 deals respectively.
The top-ranked legal advisors supporting these M&A deals in the US in 9M 2024 were Kirkland & Ellis; Weil, Gotshal & Manges; Ropes & Gray with 13, 6, 4 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.